CD29 identifies IFN-γ-producing human CD8

CD8-Positive T-Lymphocytes / immunology Cytotoxicity, Immunologic / immunology Gene Expression Profiling Humans Integrin beta1 / metabolism Interferon-gamma / metabolism Interleukin-2 / metabolism Melanoma / immunology Prognosis Skin Neoplasms / immunology Survival Rate T-Lymphocytes, Cytotoxic / immunology
CD29 IFN-γ IL-2 T cells cytotoxicity

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
24 03 2020
Historique:
pubmed: 13 3 2020
medline: 8 7 2020
entrez: 13 3 2020
Statut: ppublish

Résumé

Cytotoxic CD8

Identifiants

DOI: 10.1073/pnas.1913940117 PMID: 32161126 PMC: PMC7104308
pubmed: 32161126
pii: 1913940117
doi: 10.1073/pnas.1913940117
pmc: PMC7104308
doi:

Substances chimiques

Integrin beta1 0
Interleukin-2 0
Itgb1 protein, human 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6686-6696

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Database (Oxford). 2017 Jan 1;2017:
pubmed: 28605766
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Blood. 2013 Jul 18;122(3):405-12
pubmed: 23719298
J Immunol. 1986 Apr 1;136(7):2348-57
pubmed: 2419430
Sci Rep. 2016 May 31;6:27005
pubmed: 27243788
J Clin Invest. 2012 Mar;122(3):899-910
pubmed: 22293174
J Biotechnol. 2014 Dec 20;192 Pt A:62-5
pubmed: 25277986
J Immunol. 2017 Jan 15;198(2):962-970
pubmed: 27927969
Immunity. 2017 Nov 21;47(5):848-861.e5
pubmed: 29126798
Mol Cell. 2016 Aug 18;63(4):696-710
pubmed: 27453046
Nat Commun. 2018 Oct 23;9(1):4408
pubmed: 30352994
Hum Gene Ther Methods. 2014 Oct;25(5):277-87
pubmed: 25143008
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Blood. 2001 May 1;97(9):2758-63
pubmed: 11313268
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1607-12
pubmed: 22160692
Bioinformatics. 2017 Oct 1;33(19):3123-3125
pubmed: 28541377
Science. 1995 Dec 15;270(5243):1811-5
pubmed: 8525373
J Exp Med. 2019 May 6;216(5):1038-1049
pubmed: 30936262
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Histochem Cytochem. 2006 Jun;54(6):739-43
pubmed: 16399996
Eur J Immunol. 2018 Oct;48(10):1644-1662
pubmed: 30051906
Cell. 2013 Feb 14;152(4):743-54
pubmed: 23415224
Nat Commun. 2015 Sep 25;6:8306
pubmed: 26404698
J Immunol. 2002 Jun 15;168(12):6173-80
pubmed: 12055230
Development. 2009 Dec;136(23):3853-62
pubmed: 19906852
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
J Immunol. 2007 Mar 1;178(5):2844-52
pubmed: 17312128
Front Immunol. 2018 Oct 29;9:2512
pubmed: 30420860
J Immunol. 1989 May 15;142(10):3714-25
pubmed: 2785562
Clin Cancer Res. 2017 Oct 1;23(19):5779-5788
pubmed: 28679768
Nat Rev Genet. 2014 Dec;15(12):829-45
pubmed: 25365966
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
Genome Biol. 2016 Oct 20;17(1):218
pubmed: 27765066
Cell Immunol. 1990 Jun;128(1):314-28
pubmed: 1693101
BMC Bioinformatics. 2012 Jun 18;13:134
pubmed: 22708584
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Eur J Immunol. 2008 Aug;38(8):2251-62
pubmed: 18600823
Nat Protoc. 2018 Mar;13(3):530-550
pubmed: 29446774
Nat Med. 2002 Apr;8(4):379-85
pubmed: 11927944
Eur J Immunol. 2015 Oct;45(10):2945-58
pubmed: 26179882
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Nat Med. 2018 Jul;24(7):978-985
pubmed: 29942094
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3081-90
pubmed: 25024218
Clin Exp Immunol. 2016 Jan;183(1):37-49
pubmed: 26201441
Proteomics. 2012 Apr;12(7):1045-58
pubmed: 22318899
J Immunol. 1999 Jul 1;163(1):111-9
pubmed: 10384106
J Immunother Cancer. 2017 Nov 21;5(1):85
pubmed: 29157295
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
J Immunother Emphasis Tumor Immunol. 1994 Jul;16(1):13-23
pubmed: 8081556
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9569-74
pubmed: 22645343
J Immunol. 2006 Feb 1;176(3):1439-46
pubmed: 16424171
J Exp Med. 2007 Sep 3;204(9):2075-87
pubmed: 17698589
Cell Rep. 2017 May 2;19(5):1068-1079
pubmed: 28467900
Nat Immunol. 2016 Aug;17(8):966-75
pubmed: 27270402
Cell. 2017 Jun 15;169(7):1342-1356.e16
pubmed: 28622514
J Clin Invest. 2010 Nov;120(11):4077-90
pubmed: 20921622
Nat Med. 1998 Sep;4(9):1020-4
pubmed: 9734394
Onco Targets Ther. 2018 Mar 29;11:1787-1799
pubmed: 29636624
Cancer Discov. 2013 Apr;3(4):418-29
pubmed: 23519018
J Immunol Methods. 2018 Feb;453:3-10
pubmed: 28322863
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
J Exp Med. 1997 Nov 3;186(9):1407-18
pubmed: 9348298
Cell. 2015 Sep 10;162(6):1257-70
pubmed: 26343581
Database (Oxford). 2011 Jul 23;2011:bar030
pubmed: 21785142

Auteurs

Benoît P Nicolet (BP)

Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands.
Landsteiner Laboratory, Oncode Institute, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Aurélie Guislain (A)

Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands.
Landsteiner Laboratory, Oncode Institute, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Floris P J van Alphen (FPJ)

Department of Research Facilities, Sanquin Research, 1066 CX Amsterdam, The Netherlands.

Raquel Gomez-Eerland (R)

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Ton N M Schumacher (TNM)

Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Maartje van den Biggelaar (M)

Department of Research Facilities, Sanquin Research, 1066 CX Amsterdam, The Netherlands.
Department of Molecular and Cellular Haemostasis, Sanquin Research, 1066 CX Amsterdam, The Netherlands.

Monika C Wolkers (MC)

Department of Hematopoiesis, Sanquin Research, 1066 CX Amsterdam, The Netherlands; m.wolkers@sanquin.nl.
Landsteiner Laboratory, Oncode Institute, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Phénomènes du système immunitaire › Cytotoxicité immunologique › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de profil d'expression de gènes › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs immunologiques › Intégrines › Chaines bêta des intégrines › Antigènes CD29 › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Lymphokines › Facteurs d'activation des macrophages › Interféron gamma › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Lymphokines › Interleukine-2 › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Naevus et mélanomes › Mélanome › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Diagnostic › Pronostic › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Tumeurs cutanées › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Mortalité › Taux de survie › CD29 identifies IFN-γ-producing human CD8
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T cytotoxiques › CD29 identifies IFN-γ-producing human CD8